release date：2020-06-03
CONCLUSION AND RELEVANCE Among patients with severe or life-threatening COVID-19, convalescent plasma therapy added to standard treatment, compared with standard treatment alone, did not result in a statistically significant improvement in time to clinical improvement within 28 days. Interpretation is limited by early termination of the trial, which may have been underpowered to detect a clinically important difference.
See all: https://jamanetwork.com/journals/jama/article-abstract/2766943